OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: ETH Zurich

1 Projects | 1 Researchers | $602,590 Invested

2021

ETH Zurich

Rafael Polania, PhD

Towards an integral and sensitive neurophysiological risk biomarkers for asymptomatic detection of Alzheimer’s disease

  • Funding Amount: $602,590
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Active